Evidence map›Paper›PMID 34696187›Full record

ArticleVaccines2021

Proteome-Wide Mapping and Reverse Vaccinology Approaches to Design a Multi-Epitope Vaccine against

Fahad M Aldakheel, Amna Abrar, Samman Munir, Sehar Aslam, Khaled S Allemailem, Mohsin Khurshid, Usman Ali Ashfaq

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Design of a Novel Peptide-Based Vaccine TargetingInternational journal of dentistry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Microorganisms · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Fahad M AldakheelDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11564, Saudi Arabia.ORCID 0000-0001-8047-8650
Amna AbrarDepartment of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.
Samman MunirDepartment of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.
Sehar AslamDepartment of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.
Khaled S AllemailemDepartment of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.ORCID 0000-0002-6486-9835
Mohsin KhurshidDepartment of Microbiology, Government College University, Faisalabad 38000, Pakistan.ORCID 0000-0002-3196-2857
Usman Ali AshfaqDepartment of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.ORCID 0000-0002-5495-805X
Government College University, Faisalabad · PKKing Saud University · SAQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clostridium perfringensimmuno-iformaticsmolecular dockingsubtractive proteomicssub-unit vaccine

Identifiers

PMID34696187
PMCPMC8539331
OpenAlexW3204941160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.